Proof of concept and development of a PSMA-targeting NO-releasing PDE5 inhibitor to explore eradication for metastatic prostate cancer

Forschungsstelle

INNOSUISSE

Projektnummer

132.906 IP-LS

Projekttitel

Proof of concept and development of a PSMA-targeting NO-releasing PDE5 inhibitor to explore eradication for metastatic prostate cancer

Projekttitel Englisch

Proof of concept and development of a PSMA-targeting NO-releasing PDE5 inhibitor to explore eradication for metastatic prostate cancer

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Pharmaceuticals
Abstract (Englisch)	Topadur continues the lead optimization program to identify an innovative and unique PSMA-targeting NO-releasing PDE5 inhibitor to boost radioligand therapy in advanced prostate cancer and to generate pivotal data to support partnering development with a big pharma.